Surrey, Eric S.
Soliman, Ahmed M.
Palac, Hannah L.
Agarwal, Sanjay K.
Funding for this research was provided by:
AbbVie
Article History
First Online: 25 October 2019
Compliance with Ethical Standards
:
: This study was funded by AbbVie, North Chicago, IL, USA. AbbVie was involved in developing the study concept and participated in the analysis and interpretation of the data; preparation, review, and approval of the article; and decision to submit the article for publication.
: Eric S. Surrey is Medical Director at Colorado Center for Reproductive Medicine, has served in a consulting role for AbbVie and DOT Laboratories, received research grants from AbbVie, and served on the speaker bureau for AbbVie and Ferring Laboratories. Ahmed M. Soliman is an employee of, owns stock/stock options, and holds patents for AbbVie. Hannah L. Palac was an employee of AbbVie Inc. at the time the research was conducted. Sanjay K. Agarwal is Director of Fertility Services in the UC San Diego Department of Reproductive Medicine, Director of the UC San Diego Center for Endometriosis Research and Treatment, and has served in a consulting role on research for AbbVie Inc. and has received research support from AbbVie Inc.
: Shulman Associates Institutional Review Board (IRB) conducted the majority of the IRB approvals at each study center. The trial was conducted in accordance with the Declaration of Helsinki and International Conference on Harmonisation guidelines.
: Informed consent was obtained from all individuals participating in the study.